跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Phebra POTASSIUM CHLORIDE 22.3% 2.23 g/10 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
Phebra POTASSIUM CHLORIDE 22.3% 2.23 g/10 mL concentrated injection vial
Approved
STANDARD
Phebra POTASSIUM CHLORIDE 22.3% 2.23 g/10 mL concentrated injection vial
Phebra Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
404ca99ea703fda9
Company
Phebra Pty Ltd
Type
Standard
Approval Details
Approval Id
404ca99ea703fda9
Product Name
Phebra POTASSIUM CHLORIDE 22.3% 2.23 g/10 mL concentrated injection vial
Artg Id
23073
Artg Name
Phebra POTASSIUM CHLORIDE 22.3% 2.23 g/10 mL concentrated injection vial
Sponsor
Phebra Pty Ltd
Company Detail Path
/organization/phebra-pty-ltd
Artg Date
1991-10-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f982351698c41bc0ed274e06580e57fb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/adafccd43cd62848a33d0ab326314918.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
404ca99ea703fda9
Type
Standard
Back to TGA Approvals